Calithera Biosciences (NASDAQ:CALA) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALAFree Report) in a research report report published on Monday. The firm issued a hold rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

CALA opened at $0.03 on Monday. The business has a 50 day moving average of $0.02 and a 200-day moving average of $0.03. Calithera Biosciences has a 1-year low of $0.01 and a 1-year high of $0.50.

Calithera Biosciences Company Profile

(Get Free Report)

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.

Featured Stories

Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.